600613 神奇制药
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)2.1423.0392.4452.079--
总资产报酬率 ROA (%)1.6222.2331.7101.486--
投入资产回报率 ROIC (%)1.9192.7122.1241.781--

边际利润分析
销售毛利率 (%)47.05647.52749.93252.90460.196
营业利润率 (%)4.7404.4743.5392.7574.397
息税前利润/营业总收入 (%)4.7684.5124.0303.1614.629
净利润/营业总收入 (%)3.6553.2252.4892.0222.951

收益指标分析
经营活动净收益/利润总额(%)122.933141.661167.224124.69669.562
价值变动净收益/利润总额(%)1.5551.4102.0482.79228.222
营业外收支净额/利润总额(%)-1.690-4.6690.682-4.149-1.675

偿债能力分析
流动比率 (X)2.9793.0062.5832.286--
速动比率 (X)2.5692.5762.2292.003--
资产负债率 (%)21.92922.11327.10229.954--
带息债务/全部投入资本 (%)9.5779.13510.04613.696--
股东权益/带息债务 (%)933.698982.834883.118621.512--
股东权益/负债合计 (%)344.723342.964262.766229.432--
利息保障倍数 (X)44.73718.9868.6376.15515.222

营运能力分析
应收账款周转天数 (天)61.85562.91057.99461.5080.000
存货周转天数 (天)81.59078.89370.90367.8370.000